EB
GSK icon

Eastern Bank’s GSK GSK Stock Holding History

Eastern Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.8K Sell
1,808
-3
-0.2% -$159 ﹤0.01% 515
2026
Q1 		$99.9K Sell
1,811
-3
-0.2% -$163 ﹤0.01% 468
2025
Q4 		$89K Buy
1,814
+3
+0.2% +$140 ﹤0.01% 479
2025
Q3 		$78.2K Buy
1,811
+783
+76% +$30.6K ﹤0.01% 485
2025
Q2 		$39.5K Sell
1,028
-398
-28% -$15.2K ﹤0.01% 582
2025
Q1 		$55.2K Buy
1,426
+518
+57% +$19K ﹤0.01% 537
2024
Q4 		$30.7K Buy
908
+280
+45% +$10.1K ﹤0.01% 625
2024
Q3 		$25.7K Buy
+628
New +$25.7K ﹤0.01% 649
2015
Q3 		– Sell
-44,572
Closed -$2.32M – 205
2015
Q2 		$2.32M Buy
44,572
+1,054
+2% +$59.3K 0.19% 85
2015
Q1 		$2.51M Sell
43,518
-685
-2% -$39.3K 0.2% 85
2014
Q4 		$2.36M Buy
44,203
+102
+0.2% +$5.71K 0.19% 86
2014
Q3 		$2.53M Buy
44,101
+10,014
+29% +$614K 0.2% 83
2014
Q2 		$2.28M Buy
+34,087
New +$2.31M 0.18% 87

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

Eastern Bank's GSK Position: Q2 2026 in Review

Eastern Bank reduced its GSK (GSK) stake by 0.17% in Q2 2026, selling an estimated $159 and leaving 1,808 shares worth $94.8K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

Eastern Bank first reported a position in GSK in Q2 2014 and has held it in 13 quarters since. The position peaked at $2.53M in Q3 2014. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Eastern Bank held 1,808 shares of GSK worth $94.8K as of Q2 2026.
  • Eastern Bank sold 3 GSK shares in Q2 2026, an estimated $159.
  • GSK made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #515 holding.
  • Eastern Bank first reported a position in GSK in Q2 2014 and has held it in 13 quarters since.
  • Eastern Bank's GSK position peaked at $2.53M in Q3 2014.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.